EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Addressing Cervical Cancer Screening Disparities: At-Home Self-Collection Among LGBQ+ Populations

Colleen McNicholas, Lisa Memmel, Clair Kaplan, Youri Hwang iD, LaShonda Crane, Ronald Orso, Kimberly Harshberger, R Lamar Parker, Ann Collins, Christine Conageski iD, Sangini Sheth, Lindsay Kuroki iD und 8 weitere

Cancer Control · 2026-05 · 33

DOI: 10.1177/10732748261448263 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Cancer Control, online erschienen am 06.05.2026. Verfasst von Colleen McNicholas und 19 weiteren Autor:innen. Beteiligte Einrichtung: Planned Parenthood Great Northwest, Hawaii, Alaska, Indiana, Kentucky, Obstetrics and Gynecology, St. Louis, MO, US. Hauptthemen laut MEDLINE: Early Detection of Cancer, Papillomavirus Infections, Sexual and Gender Minorities, Specimen Handling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institutes of Health, Teal Health, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Over 20 million people in the U.S. are behind on cervical cancer screenings (CCS). Sexual minority populations are 50% less likely to engage in routine screening, putting them at higher risk for cervical dysplasia and cancer due to undetected precancer and delayed diagnosis. Their barriers to speculum exams include access to care, sexual trauma, and provider bias. At-home HPV self-collection (SC) offers a clinically accurate, preferred alternative screening method.

Objective

To assess clinical agreement, usability, and screening experiences and preferences for an FDA-authorized at-home vaginal SC device among participants who identify as lesbian, gay, bisexual, pansexual, queer, or other non-heterosexual identities (LGBQ+).

Methods

SELF-CERV was a prospective, multi-site method-comparison study conducted across 16 U.S. sites. Participants completed SC in a simulated at-home setting and underwent clinician collection with a speculum and cervical brush; paired specimens were tested for primary HPV using the Roche cobas. Surveys assessed barriers to screening, prior screening experiences, usability, and preferences. 609 participants were enrolled; 599 had paired samples, including 74 LGBQ+ participants.

Results

Compared with heterosexual participants, LGBQ+ participants more frequently delayed or avoided screening, had lower preventive care engagement, and described worse prior speculum-based screening experiences, including higher pain, discomfort, and aversion. Clinical agreement between self- and clinician-collected specimens was comparable, with no unanticipated safety concerns. The SC device was rated as easy to use and acceptable across groups; LGBQ+ participants reported greater comfort and empowerment and a stronger preference for at-home self-collection. Qualitative comments emphasized privacy and reduced distress, including trauma- and dysphoria-related concerns.

Conclusion

At-home SC is a clinically valid, usable, and strongly preferred CCS option, particularly among LGBQ+ populations who experience disproportionate barriers to speculum-based CCS. Broader adoption of FDA-authorized at-home SC paired with telehealth will enable future impact assessment to reduce persistent disparities in CCS for LGBQ+ populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerPapillomavirus InfectionsSexual and Gender MinoritiesSpecimen HandlingUterine Cervical NeoplasmsAdultFemaleHumansMiddle AgedHuman Papillomavirus VirusesProspective StudiesSelf CareUnited States

Stichwörter der Autor:innen

HPV primary screeningHPV self-collectioncervical cancer screeningsexual minority healthtelehealthtrauma-informed care

Autor:innen und Institutionen

  • Planned Parenthood Great Northwest, Hawaii, Alaska, Indiana, Kentucky, Obstetrics and Gynecology, St. Louis, MO, US.
  • Planned Parenthood Northern California, Obstetrics and Gynecology, San Francisco, CA, US.
  • Planned Parenthood of Southern New England, Clinical Research, Hartford, CT, US.
  • Planned Parenthood League of Massachusetts, Clinical Research, Boston, MA, US.
  • Planned Parenthood Gulf Coast, Inc, Clinical Research, Houston, TX, US.
  • Alabama Clinical Therapeutics/Birmingham OBGYN, Obstetrics and Gynecology, Birmingham, AL, US.

ORCID-Profile: Youri Hwang, Christine Conageski, Lindsay Kuroki, Jenell Coleman, Elizabeth Sutton, Emeline Aviki, Megan Fitzpatrick, Alexandra Ripkin, Meghna Mukherjee

Förderung

  • National Institutes of Health
  • Teal Health, Inc.

Zitieren

APA

McNicholas, C., Memmel, L., Kaplan, C., Hwang, Y., Crane, L., Orso, R., Harshberger, K., Parker, R. L., Collins, A., Conageski, C., Sheth, S., Kuroki, L., Coleman, J., Sutton, E., Jennings, A., Aviki, E., Fitzpatrick, M., Hibler, K., Ripkin, A., & Mukherjee, M. (2026). Addressing Cervical Cancer Screening Disparities: At-Home Self-Collection Among LGBQ+ Populations. Cancer Control, 33. https://doi.org/10.1177/10732748261448263

Vancouver

McNicholas C, Memmel L, Kaplan C, Hwang Y, Crane L, Orso R, et al. Addressing Cervical Cancer Screening Disparities: At-Home Self-Collection Among LGBQ+ Populations. Cancer Control. 2026;33. doi:10.1177/10732748261448263

BibTeX
@article{McNicholas2026,
  author = {McNicholas, Colleen and Memmel, Lisa and Kaplan, Clair and Hwang, Youri and Crane, LaShonda and Orso, Ronald and Harshberger, Kimberly and Parker, R Lamar and Collins, Ann and Conageski, Christine and Sheth, Sangini and Kuroki, Lindsay and Coleman, Jenell and Sutton, Elizabeth and Jennings, Ashley and Aviki, Emeline and Fitzpatrick, Megan and Hibler, Karl and Ripkin, Alexandra and Mukherjee, Meghna},
  title = {Addressing Cervical Cancer Screening Disparities: At-Home Self-Collection Among LGBQ+ Populations},
  journal = {Cancer Control},
  year = {2026},
  volume = {33},
  doi = {10.1177/10732748261448263}
}
Kostenlos starten →